When will Covid decline in India? Anand Mahindra cites study showing ‘glimmer of light’

At a time when the number of active Covid-19 cases in India during the second wave is expected to peak in May, industry leader Anand Mahindra took to Twitter to quote a study showing a ‘glow of light in the dark’ in the middle a surge in Covid-19 Cases nationwide.

Referring to the ATE Chandra Foundation model, the chairman of the Mahindra group said, “A glimmer of light in the dark. It is from Mumbai. Through the pandemic, I have been relying on the excellent insights of the ATE Chandra Foundation. Their model shows encouraging trend. Mumbai’s daily incidence has plateaued over the past week, so Seroprevalence in Mumbai (the existence of Covid antibodies) is high at 40% + and rising rapidly due to new infections and vaccinations. “

“Global evidence suggests that we can reach a tipping point at around 60-65% where daily incidence is declining sharply. Just like in the UK, Mahindra tweeted.

In another tweet, he wrote, “The key to easing this trend is accelerating vaccinations. The accompanying chart shows the impact of a strong US vaccination drive”

“And responsible citizens are reducing the burden on an overloaded healthcare system and facilitating early locksmithing. This statistical projection made by @ATEChandrafdn could become a reality in Mumbai and also the way forward for the rest of the country, “he added.

Nearly 3 lakh Covid cases in India, 2,023 deaths

Covid-19 has infected 2,95,041 people in India and left 2,023 dead in a day, in a serious new record for the country. Encouraging self-discipline, Prime Minister Narendra Modi on Tuesday said that states must only use locks as a last resort.

The total number of deaths has increased to 1,82,553 after the massive one-day spike. This is the seventh straight day of over two lakh new cases in India. The country’s total of over 1.56 crore Covid-19 cases is the second highest globally, behind the United States and ahead of Brazil.

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

.Source